Abstract
The two predominant pathological concomitants of Alzheimer’s disease (AD) are senile plaques and neurofibrillary tangles. Although many biochemical studies have addressed the composition and formation of these AD hallmarks, very little is known about the interrelationship between the two. Here we present evidence that the tau phosphorylation characteristic of neurofibrillary tangles may be mediated by a physical association of MKK6 (mitogen-associated protein kinase kinase 6) with tau and subsequent phosphorylation of tau by the MKK6 substrate, p38 MAPK; and that APP (β-amyloid precursor protein) may be co-immunoprecipitated both with MKK6 and its upstream MAPKKK, ASK1. Taken together with recent data demonstrating APP dimerization by β-amyloid peptide (Aβ) (Lu et al., 2003), and the possible activation of ASK1 via APP dimerization (Hashimoto et al., 2003), these results suggest a model of AD in which Aβ peptide dimerizes APP directly, leading to the activation of ASK1, MKK6, and p38, with subsequent phosphorylation of tau at sites characteristic of AD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Delacourte A., David J. P., Sergeant N., et al. (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease. Neurology 52, 1158–1165.
Ferrer I., Blanco R., Carmona M., and Puig B. (2001) Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J. Neural Transm. 108, 1397–1415.
Gamblin T. C., Berry R. W., and Binder L. I. (2003) Tau polymerization: role of the amino terminus. Biochemistry 42, 2252–2257.
Giannakopoulos P., Herrmann F. R., Bussiere T., et al. (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology 60, 1495–1500.
Goedert M., Hasegawa M., Jakes R., Lawler S., Cuenda A., and Cohen P. (1997) Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 409, 57–62.
Hartzler A. W., Zhu X., Siedlak S. L., et al. (2002) The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau. Neurobiol. Aging 23, 855–859.
Hashimoto Y., Niikura T., Chiba T., et al. (2003) The cytoplasmic domain of Alzheimer’s amyloid-beta protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH2-terminal kinase-mediated neurotoxic signal via dimerization. J. Pharmacol. Exp. Ther. 306, 889–902.
Hensley K., Floyd R. A., Zheng N. Y., et al. (1999) p38 Kinase is activated in the Alzheimer’s disease brain. J. Neurochem. 72, 2053–2058.
Ichijo H. (1999) From receptors to stress-activated MAP kinases. Oncogene 18, 6087–6093.
Ichijo H., Nishida E., Irie K., et al. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90–94.
Ihara Y., Kondo J., Miura R., Nakagawa Y., Mori H., and Honda T. (1990) Characterization of antisera to paired helical filaments and tau. Implication for the extent of tau tightly bound to paired helical filaments. Gerontology 36(Suppl.1), 15–24.
Lee V. M., Goedert M., and Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121–1159.
Lewis J., Dickson D. W., Lin W. L., et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487–1491.
Lu D. C., Rabizadeh S., Chandra S., et al. (2000) A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat. Med. 6, 397–404.
Lu D. C., Shaked G. M., Masliah E., Bredesen D. E., and Koo E. H. (2003) Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes. Ann. Neurol. 54, 781–789.
Matsuda S., Yasukawa T., Homma Y., et al. (2001) c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer’s amyloid precursor protein with JNK. J. Neurosci. 21, 6597–6607.
Morishima M. and Ihara Y. (1994) Posttranslational modifications of tau in paired helical filaments. Dementia. 5, 282–288.
Oddo S., Caccamo A., Shepherd J. D., et al. (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 39, 409–421.
Peel A. and Bredesen D. (2003) Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice. Neurobiol. Dis. 14, 52–62.
Reynolds C. H., Nebreda A. R., Gibb G. M., Utton M. A. and Anderton B. H. (1997) Reactivating kinase/p38 phosphorylates tau protein in vitro. J. Neurochem. 69, 191–198.
Scheinfeld M. H., Roncarati R., Vito P., Lopez P. A., Abdallah M., and D’Adamio L. (2002) Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer’s beta-amyloid precursor protein (APP). J. Biol. Chem. 277, 3767–3775.
Scott C. W., Fieles A., Sygowski L. A., and Caputo C. B. (1993) Aggregation of tau protein by aluminum. Brain Res. 628, 77–84.
Spillantini M. G. and Goedert M. (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21, 428–433.
Standen C. L., Brownlees J., Grierson A. J., et al. (2001) Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer’s disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3). J. Neurochem. 76, 316–320.
Taru H., Iijima K., Hase M., Kirino Y., Yagi Y., and Suzuki T. (2002) Interaction of Alzheimer’s beta-amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade. J. Biol. Chem. 277, 20,070–20,078.
Tomidokoro Y., Ishiguro K., Igeta Y., et al. (1999) Carboxyl-terminal fragments of presenilin-1 are closely related to cytoskeletal abnormalities in Alzheimer’s brains. Biochem. Biophys. Res. Commun. 256, 512–518.
Zhu X., Lee H. G., Raina A. K., Perry G., and Smith M. A. (2002) The role of mitogen-activated protein kinase pathways in Alzheimer’s disease. Neurosignals 11, 270–281.
Zhu X., Rottkamp C. A., Boux H., Takeda A., Perry G., and Smith M. A. (2000) Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer’s disease. J. Neuropathol. Exp. Neurol. 59, 880–888.
Zhu X., Rottkamp C. A., Hartzler A., et al. (2001) Activation of MKK6, an upstream activator of p38, in Alzheimer’s disease. J. Neurochem. 79, 311–318.
Zhu X., Sun Z., Lee H. G., Siedlak S. L., Perry G., and Smith M. A. (2003) Distribution, levels, and activation of MEK1 in Alzheimer’s disease. J. Neurochem. 86, 136–142.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peel, A.L., Sorscher, N., Kim, J.Y. et al. Tau phosphorylation in Alzheimer’s disease. Neuromol Med 5, 205–218 (2004). https://doi.org/10.1385/NMM:5:3:205
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/NMM:5:3:205